High risk breast cancer: Prospective data about the role of FDG PET/CT in pre- and post-operative settings
Silvia Michieletto(Istituto Oncologico Veneto), Fernando A. Bozza(D’Or Institute for Research and Education), Tania Saibene(Istituti di Ricovero e Cura a Carattere Scientifico), Laura Evangelista(Istituto Oncologico Veneto), F. Barbazza(Istituto Oncologico Veneto), R. Grigoletto(Istituto Oncologico Veneto)
Cited by 0
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
|Blood|2020|776
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
|Critical Care|2007|744
Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data
|The Lancet Respiratory Medicine|2021|527
A Central Role for Free Heme in the Pathogenesis of Severe Sepsis
|Science Translational Medicine|2010|492